Form D · Other
King Therapeutics LLC
Phoenix, AZ · CIK 0002088073
Offering snapshot reported Oct 15, 2025 · SEC filing
- Reported sold
- $310K Offering amount: $500K
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 11, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2025 | Initial | $310,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-560923
Simple Agreement for Future Equity
Source: Form D, filed Oct 15, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dmitry Derkach | Director |
| David Richardson | Director, Executive |
| Isaiah Slemons | Director |
Issuer details
Industry: Other (See others in industry)
Address:
12006 S. 44 Th St.
Phoenix, AZ, 85044
Phoenix, AZ, 85044